Pharmacy Daily | CMA urges deregulation

Complementary Medicines Australia says the government review of regulation around complementary medicines provides “the perfect opportunity for greater international streamlining of regulatory requirements”. In a submission to the Department of Health, CMA says the complementary medicines industry has the ability to “grow exponentially” given a supportive business environment. CEO Carl Gibson said the organisation’s recommendations focus on areas of simplification to create an “appropriate regulatory regime” which is supportive of innovation and competitiveness, but doesn’t undermine the current high standards for Australian CMs. “Removal of excessive regulatory burden, and a greater focus on international harmonisation, will assist the complementary medicines industry to bring innovative new products to the Australian market,” he said. The submission says the CM sector also holds enormous potential to contribute to a sustainable healthcare system.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 15
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 15